Four-Year Outcomes for Nivolumab With Chemotherapy and Bevacizumab in Patients With Nonsquamous NSCLC in the TASUKI-52.
Phase III TASUKI-52: 4-year outcomes Population & design - Untreated advanced nonsquamous NSCLC. - Randomized 1:1 t...
Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII).
- Post category:Respiratory (Lung, Bronchus) System
- Reading time:2 mins read
This phase III randomized superiority trial compared ultra-low-dose nivolumab with standard single-agent chemotherapy (d...
First Things First: Navigating ALK-Positive Metastatic Non-Small Cell Lung Cancer Treatment Options-A Podcast.
- Post category:Respiratory (Lung, Bronchus) System
- Reading time:2 mins read
This publication is a podcast-style discussion on current management of metastatic ALK‑positive NSCLC, with an emphasi...
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.
- Post category:Respiratory (Lung, Bronchus) System
- Reading time:2 mins read
This phase 2, multicenter, open-label trial (FMT-LUMINate; NCT04951583) evaluated whether a single fecal microbiota tran...
Large-scale plasma proteomics reveals bidirectional associations between sleep patterns and inflammatory bowel disease: a prospective cohort study.
- Post category:Respiratory (Lung, Bronchus) System
- Reading time:2 mins read
This study examined how unhealthy sleep and inflammatory bowel disease (IBD) influence each other and explored circulati...
Third-Generation EGFR-TKIs Combined With Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Real-World Study.
- Post category:Respiratory (Lung, Bronchus) System
- Reading time:1 min read
This retrospective real-world study evaluated the efficacy and safety of third-generation EGFR-TKIs combined with platin...